Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 307Lung Neoplasms 111Adenocarcinoma of Lung 23Non-Squamous Non-Small Cell Lung Cancer 21Neoplasms 21Adenocarcinoma, Bronchiolo-Alveolar 15Brain Neoplasms 14Neoplasm Metastasis 10Squamous Cell Carcinoma of Head and Neck 5Respiratory Tract Diseases 5Carcinoma 5Breast Neoplasms 5Adenocarcinoma 5Thoracic Neoplasms 4Recurrence 4Pancreatic Neoplasms 4NSCLC 4Colorectal Neoplasms 4Colonic Neoplasms 4Salivary Gland Neoplasms 3Respiratory Tract Neoplasms 3Rectal Neoplasms 3Lung Diseases 3Esthesioneuroblastoma, Olfactory 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Thymoma 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Pleural Effusion, Malignant 2

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3Nivolumab 2Biopsy 2pembrolizumab 1cabozantinib 1Vorinostat 1Tomography, X-Ray Computed 1Taxes 1Spirometry 1Paclitaxel 1Ipilimumab 1Gene Expression Profiling 1Flow Cytometry 1Erlotinib Hydrochloride 1Carboplatin 1CTLA-4 Antigen 1Antiretroviral Therapy, Highly Active 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Erlotinib Hydrochloride × Thoracic × Clear all
NCT02134886 2015-10-06

Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection

National Cancer Institute (NCI)

Phase 1 Terminated
48 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡